Porcine Epidemic Diarrhea Vaccines Market Insights Highlighting Opportunities Supporting Growth To 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Porcine Epidemic Diarrhea Vaccines Market From 2026 To 2030?
The porcine epidemic diarrhea vaccines market size has shown considerable growth in recent years. It is projected to expand from $1.8 billion in 2025 to $1.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The observed growth in the historic period can be attributed to persistent outbreaks of porcine epidemic diarrhea, elevated mortality rates among neonatal piglets, financial setbacks in the swine industry, the constrained effectiveness of non-vaccine disease control measures, and an increased reliance on veterinary-led disease prevention.
The porcine epidemic diarrhea vaccines market is expected to demonstrate significant expansion in the coming years. It is projected to achieve a value of $2.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth can be attributed to several factors, including the increase in intensive pig farming practices, the rising worldwide demand for pork products, a greater understanding of the advantages of herd immunity, the spread of organized hog production farms, and supportive government initiatives concerning animal health. Prominent trends expected in the forecast period involve a heightened adoption of preventive vaccination within swine health management, a growing preference for live vaccines in regions where the disease is common, an increased emphasis on the early immunization of piglets, the extension of vaccination programs in commercial hog farms, and a stronger focus on biosecurity and disease control protocols.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
Which Major Drivers Are Influencing The Expansion Of The Porcine Epidemic Diarrhea Vaccines Market?
The escalating practice of pig farming is anticipated to drive the expansion of the porcine epidemic diarrhea vaccine market in the forthcoming period. This agricultural activity encompasses the raising of domestic pigs for meat, their breeding, rearing, and management from birth to market weight, alongside the production and marketing of pork products. The surge in pig farming is fueled by increasing global demand for pork, progress in breeding and herd management techniques, enhancements in swine production technologies, and the expansion of commercial pork sectors. Porcine epidemic diarrhea (PED) vaccines are essential in pig farming, assisting in the prevention and control of disease outbreaks, commonly administered during a sow’s gestation to impart passive immunity to newborn piglets. For example, in April 2024, the U.S. Department of Agriculture, a US-based government agency, forecast U.S. pork production to hit 12.7 million metric tons, indicating a rise in swine output and thereby backing the ongoing growth of the pig farming industry. Consequently, the expansion of pig farming is stimulating the growth of the porcine epidemic diarrhea vaccine market.
How Is The Porcine Epidemic Diarrhea Vaccines Market Segmented Across Different Segment Categories?
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
What Trends Are Transforming The Porcine Epidemic Diarrhea Vaccines Market?
Leading companies within the Porcine Epidemic Diarrhea (PED) vaccines market are concentrating on the development of innovative solutions, including next-generation inactivated and recombinant vaccines, to improve immunity and deliver broader safeguarding against emergent PEDV strains. Next-generation inactivated and recombinant vaccines represent advanced immunization methods that utilize either deactivated viruses or engineered viral proteins to stimulate strong, targeted immune responses, simultaneously enhancing safety and defense against evolving disease strains. As an illustration, in August 2024, Zoetis Inc., a US-based animal health company, received funding for Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and was also granted a conditional license by the U.S. Department of Agriculture (USDA) for a vaccine intended to combat PEDV in pigs. These endeavors reinforce Zoetis’s critical contribution to developing sophisticated swine health solutions by supporting further scientific inquiry, improving vaccine effectiveness, and extending protection against new PEDV strains.
Which Organizations Play A Role In The Porcine Epidemic Diarrhea Vaccines Market Landscape?
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines
Get The Full Porcine Epidemic Diarrhea Vaccines Market Report:
Which Region Leads The Porcine Epidemic Diarrhea Vaccines Market In Overall Market Size?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Porcine Epidemic Diarrhea Vaccines Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Porcine Epidemic Diarrhea Vaccines Market 2026, By The Business Research Company
Porcine Epidemic Diarrhea Vaccines Market Report 2026
Porcine Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Swine Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
